Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction

Sodium –glucose linked cotransporter-2 (SGLT2) inhibitors reduce the likelihood of hospitalization for heart failure and cardiovascular death in both diabetic and non-diabetic individuals with reduced ejection ...

Source: Cardiovascular Diabetology - February 8, 2020 Category: Cardiology Authors: Kim A. Connelly, Yanling Zhang, Jean-Fran çois Desjardins, Linda Nghiem, Aylin Visram, Sri N. Batchu, Verra G. Yerra, Golam Kabir, Kerri Thai, Andrew Advani and Richard E. Gilbert Tags: Original investigation Source Type: research